Clinical trial
A Pilot Study of Imatinib in the Treatment of Refractory Systemic Sclerosis
NCT00506831 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Imatinib in the Treatment of Refractory Systemic Sclerosis
- Lead sponsor
- Stanford University
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- July 31, 2007
- Completion date
- September 30, 2010
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.